BTIG Initiates Coverage On Apyx Medical with Neutral Rating
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Sam Eiber has initiated coverage on Apyx Medical with a Neutral rating, indicating a balanced view on the stock's potential performance.
October 17, 2024 | 9:58 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
BTIG analyst Sam Eiber has initiated coverage on Apyx Medical with a Neutral rating, suggesting a balanced view on the stock's potential performance.
The Neutral rating from BTIG indicates that the analyst does not see significant upside or downside potential in the short term for Apyx Medical. This suggests that the stock may not experience significant price movement based on this rating alone.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100